High-performance liquid chromatographic analysis of verapamil and its application to determination in tablet dosage forms and to drug dissolution studies

Farmaco

Volumn 55, Issue 5, 2000, Pages 376-382

  Özkan, Yalçin ^a   Yilmaz, Niyazi ^b   Özkan, Sibel A ^b   Biryol, Inci ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Dissolution profile; Fluorimetric detector; High performance liquid chromatography; Tablet analysis; UV detector; Verapamil hydrochloride

Indexed keywords

FLUOXETINE; VERAPAMIL;

ARTICLE; DRUG SOLUBILITY; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUALITY CONTROL; QUANTITATIVE ASSAY; TABLET FORMULATION;

CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; VERAPAMIL;

EID: 0033851110     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(00)00054-9     Document Type: Article

References (20)

1. J.E.F. Reynolds (Ed.), Martindale, The Extra Pharmacopoeia, 29th ed., Pharmaceutical Press, London, 1989, pp. 89-91.
2. J.G. Hardman, L.E. Limbird (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York, 1996, p. 855.
3. Long Y., Feng J., Tong S. Spectrophotometry of verapamil tablets with charge transfer reaction. Zhongguo Yiyao Gongye Zazhi. 24:1993;267-270.
4. Drummer O.H., Horomidis S., Kourtis S., Syrjanen M.L., Tippett P. Capillary gas chromatographic drug screen for use in forensic toxicology. J. Anal. Toxicol. 18:1994;134-138.
5. Soini H., Riekkala M.L., Novotny M.V. Chiral separations of basic drugs and quantitation of bupivacaine enantiomers in serum by capillary electrophoresis with modified cyclodextrin buffers. J. Chromatogr. 608:1992;265-274.
6. El Ghany M.F.A., Moustafa A.A., Elzeany B.E., Stewart J.T. High-performance thin-layer chromatographic analysis of verapamil hydrochloride in drug substance and dosage forms. J. Planar. Chromatogr. Mod. TLC. 9:1990;388-390.
7. Rustum A.M. Measurement of verapamil in human plasma by reversed-phase high-performance liquid chromatography using a short octyl column. J. Chromatogr. 528:1990;480-486.
8. Garcia M.A., Aramayana J.J., Bregante M.A., Fraile L.J., Solans C. Simultaneous determination of verapamil and norverapamil in biological samples by high-performance liquid chromatography using ultraviolet detection. J. Chromatogr. B. 693:1997;377-382.
9. US Pharmacopoeia, 23rd rev., 18th ed., Easton, Rand McNally, Taunton, MA, 1995, p. 1625.
10. Sioufi A., Marfil F., Godbillon J. Automated determination of an angiotensin II receptor antagonist CGP 48 933, in plasma by high-performance liquid chromatography. J. Liq. Chromatogr. 17:1994;2179-2186.
11. Ceccato A., Chiapi P., Hubert P., Toussaint B., Crommen J. Automated determination of verapamil and norverapamil in human plasma with on-line coupling of dialysis to high-performance liquid chromatography and fluorometric detection. J. Chromatogr. A. 750:1996;351-360.
12. Köppel C., Wagemann A. Plasma level monitoring of DL-verapamil and three of its metabolites by reversed-phase high-performance liquid chromatography. J. Chromatogr. 570:1991;229-234.
13. Jane I., McKinnon A., Flanagan R.J. High-performance liquid chromatographic analysis of basic drugs on silica columns using non-aqueous ionic eluents. II: Application of UV, fluorescence and electrochemical oxidation detection. J. Chromatogr. 323:1985;191-225.
14. Morrison A.B., Campbell J.A. Tablet disintegration and physiological availability of drugs. J. Parm. Sci. 54:(1):1965;1-8.
15. Jashnani R.N., Byron P.R., Dalby R.N. Validation of an improved wood's rotating disk dissolution apparatus. J. Pharm. Sci. 82:1993;670-671.
16. Anchisi C., Baroli B.M., Fadda A.M., Manconi M., Sinico C., Valenti D. Dissolution properties of Flurazepam capsules. Farmaco. 53:1998;662-666.
17. Satiropoulus J.B., Deutsch T., Plakogiannis F.M. Comparative bioavailability of three commercial acetaminophen tablets. J. Pharm. Sci. 70:1981;422-425.
18. Rowe J.S., Carless J.E. Comparison at the in vitro dissolution behavior of various indomethacin formulations with their in vivo bioavailability. J. Parm. Pharmacol. 33:1981;561-565.
19. Langenbucher F. Parametric representation of dissolution rate curves by the RRSBW distribution. Pharm. Ind. 38:1976;472-477.
20. Higuchi T. Mechanism of sustained action medication. J. Pharm. Sci. 52:1963;1145-1149.